Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling
- 7 April 2016
- journal article
- video audio-media
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 110 (3) , 381-394
Abstract
Down syndrome-associated dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A (DYRK1A) is a ubiquitously expressed protein kinase. Up to date a variety of targets have been identified, establishing a key role for Dyrk1a in selected signalling pathways. In cardiomyocytes, Dyrk1a acts as a negative regulator of hypertrophy by phosphorylating transcription factors of the NFAT family, but its mechanistic function in the heart remains poorly understood. This study was designed to investigate a potential protective role of Dyrk1a in cardiac hypertrophy in vivo. We generated transgenic mice with cardiac-specific overexpression of Dyrk1a. Counterintuitively, these mice developed severe dilated cardiomyopathy associated with congestive heart failure and premature death. In search for the cause of this unexpected phenotype, we found that Dyrk1a interacts with all members of the D-cyclin family and represses their protein levels in vitro and in vivo. Particularly, forced expression of Dyrk1a leads to increased phosphorylation of Ccnd2 on Thr280 and promotes its subsequent proteasomal degradation. Accordingly, cardiomyocytes overexpressing Dyrk1a display hypo-phosphorylated Rb1, suppression of Rb/E2f-signalling, and reduced expression of E2f-target genes, which ultimately results in impaired cell cycle progression. We identified Dyrk1a as a novel negative regulator of D-cyclin-mediated Rb/E2f-signalling. As dysregulation of this pathway with impaired cardiomyocyte proliferation leads to cardiomyopathy, dose-specific Dyrk1a expression and activity appears to be critical for the hyperplastic and hypertrophic growth of the developing heart.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (DFG KU 2721/1-1)
This publication has 69 references indexed in Scilit:
- Structures of Down Syndrome Kinases, DYRKs, Reveal Mechanisms of Kinase Activation and Substrate RecognitionStructure, 2013
- Adenovirus E1A Directly Targets the E2F/DP-1 ComplexJournal of Virology, 2011
- Regulation of the cardiomyocyte population in the developing heartProgress in Biophysics and Molecular Biology, 2011
- DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assemblyGenes & Development, 2011
- DYRK1A Is a Novel Negative Regulator of Cardiomyocyte HypertrophyJournal of Biological Chemistry, 2009
- Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome ProjectGenetics in Medicine, 2008
- Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarctionCardiovascular Research, 2007
- Cardiac Myocyte Cell Cycle Control in Development, Disease, and RegenerationPhysiological Reviews, 2007
- Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2‐dependent pathwayThe EMBO Journal, 2006
- NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21Nature, 2006